FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
Authors
Keywords
FGF19, FGFR4, Hepatocellular carcinoma, Drug resistance, Sorafenib, Synergistic effect
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 36, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-01-09
DOI
10.1186/s13046-016-0478-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abstract 2984: Plumbagin induces p53-dependent apoptosis via generation of reactive oxygen species in human cancer cells
- (2016) Umasankar De et al. CANCER RESEARCH
- Abstract 4810: Histone deacetylase 2 is a potential determinant of the sensitivity of hepatocellular carcinoma cells to sorafenib
- (2016) Hyung Seok Kim et al. CANCER RESEARCH
- Abstract 1720: Role of SENP1 in HBx-induced cell migration and stemness-related properties in hepatocellular carcinoma
- (2016) Te Sheng Chang et al. CANCER RESEARCH
- Exploiting plug-and-play electrochemistry for drug discovery
- (2016) Lixia Gao et al. Future Medicinal Chemistry
- Increased FGF19 copy number is frequently detected in hepatocellular carcinoma with a complete response after sorafenib treatment
- (2016) Masaki Kaibori et al. Oncotarget
- Abstract B111: Efficacy of AKT inhibitor ARQ 092 compared with Sorafenib in a cirrhotic rat model with hepatocellular carcinoma
- (2015) Gael S. Roth et al. MOLECULAR CANCER THERAPEUTICS
- First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
- (2015) M. Hagel et al. Cancer Discovery
- Separating Tumorigenicity from Bile Acid Regulatory Activity for Endocrine Hormone FGF19
- (2014) M. Zhou et al. CANCER RESEARCH
- ROS Function in Redox Signaling and Oxidative Stress
- (2014) Michael Schieber et al. CURRENT BIOLOGY
- Emerging trends in hepatocellular carcinoma incidence and mortality
- (2014) Basile Njei et al. HEPATOLOGY
- Involvement of superoxide and nitric oxide in BRAFV600E inhibitor PLX4032-induced growth inhibition of melanoma cells
- (2014) Ling Yu et al. Integrative Biology
- FGFR4 and TGF-β1 Expression in Hepatocellular Carcinoma: Correlation with Clinicopathological Features and Prognosis
- (2014) Zhixin Chen et al. International Journal of Medical Sciences
- Combination Strategy Targeting VEGF and HGF/c-met in Human Renal Cell Carcinoma Models
- (2014) E. Ciamporcero et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma
- (2014) B. Zhai et al. MOLECULAR CANCER THERAPEUTICS
- Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization
- (2013) Riad Salem et al. Clinical Gastroenterology and Hepatology
- Selenocystine potentiates cancer cell apoptosis induced by 5-fluorouracil by triggering reactive oxygen species-mediated DNA damage and inactivation of the ERK pathway
- (2013) Cundong Fan et al. FREE RADICAL BIOLOGY AND MEDICINE
- Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
- (2013) Z. Kan et al. GENOME RESEARCH
- Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma
- (2013) Kai Wang et al. HEPATOLOGY
- Fibroblast growth factor signaling in liver carcinogenesis
- (2013) Dalbir S. Sandhu et al. HEPATOLOGY
- Effects of miR-193a and sorafenib on hepatocellular carcinoma cells
- (2013) Alessandro Salvi et al. Molecular Cancer
- Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
- (2012) Seiki Miura et al. BMC CANCER
- The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis
- (2012) Joanne Chiu et al. CANCER
- Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
- (2012) Hannah van Malenstein et al. CANCER LETTERS
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling
- (2012) Paul D. Ray et al. CELLULAR SIGNALLING
- Second-Line Therapies in Hepatocellular Carcinoma: Emergence of Resistance to Sorafenib
- (2012) A. Villanueva et al. CLINICAL CANCER RESEARCH
- Radioembolization for hepatocellular carcinoma with portal vein thrombosis: Impact of liver function on systemic treatment options at disease progression
- (2012) Khairuddin Memon et al. JOURNAL OF HEPATOLOGY
- Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo
- (2012) R. Coriat et al. MOLECULAR CANCER THERAPEUTICS
- Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
- (2011) Eric T. Sawey et al. CANCER CELL
- NADPH oxidase-dependent oxidative stress in the failing heart: From pathogenic roles to therapeutic approach
- (2011) Yanti Octavia et al. FREE RADICAL BIOLOGY AND MEDICINE
- In vitro detection of superoxide anions released from cancer cells based on potassium-doped carbon nanotubes–ionic liquid composite gels
- (2011) Xiao-Rong Li et al. Nanoscale
- Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention
- (2008) Han Kiat Ho et al. JOURNAL OF HEPATOLOGY
- Mini-Review: Endocrine Actions of Fibroblast Growth Factor 19
- (2008) Stacey Jones MOLECULAR PHARMACEUTICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started